Post-earnings recap
Reported
Wed, Jul 17, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an earnings per share (EPS) of $0.46, exceeding expectations by 4.31%. However, no revenue figures were disclosed. The stock reacted positively, rising by 0.34%, indicating some investor confidence following the earnings report despite the lack of additional guidance or commentary.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +4.31% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—